SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly

A taskforce of the International Society of Geriatric Oncology (SIOG) has recently submitted recommendations on the use of anthracyclines in elderly patients. Despite the aging of the population and the high proportion of elderly individuals in the population of patients with non-Hodgkin’s lymphoma,...

Full description

Bibliographic Details
Main Author: Matti Aapro
Format: Article
Language:English
Published: MDPI AG 2011-10-01
Series:Hematology Reports
Subjects:
Online Access:http://www.pagepress.org/journals/index.php/hr/article/view/3873
_version_ 1811173796877434880
author Matti Aapro
author_facet Matti Aapro
author_sort Matti Aapro
collection DOAJ
description A taskforce of the International Society of Geriatric Oncology (SIOG) has recently submitted recommendations on the use of anthracyclines in elderly patients. Despite the aging of the population and the high proportion of elderly individuals in the population of patients with non-Hodgkin’s lymphoma, the development of specialist expertise in the treatment of elderly patients with cancer is relatively recent. Treatment of the elderly is complex because they are a highly heterogeneous population, with large variations in health status, comorbidities and life expectancy. In addition, these patients are generally more susceptible than young patients to the cardiotoxic effects of anthracyclines. Strategies for assessing elderly patients with cancer, reducing the risk of congestive heart failure, and assessing the cardiotoxic effects of treatments are discussed. In addition, a summary of the SIOG recommendations is presented.
first_indexed 2024-04-10T17:52:51Z
format Article
id doaj.art-510a3ce657834209a9591e31f948da41
institution Directory Open Access Journal
issn 2038-8322
2038-8330
language English
last_indexed 2024-04-10T17:52:51Z
publishDate 2011-10-01
publisher MDPI AG
record_format Article
series Hematology Reports
spelling doaj.art-510a3ce657834209a9591e31f948da412023-02-02T19:42:15ZengMDPI AGHematology Reports2038-83222038-83302011-10-0133se6e610.4081/hr.2011.s3.e61764SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderlyMatti Aapro0Multidisciplinary Oncology Institute, GenolierA taskforce of the International Society of Geriatric Oncology (SIOG) has recently submitted recommendations on the use of anthracyclines in elderly patients. Despite the aging of the population and the high proportion of elderly individuals in the population of patients with non-Hodgkin’s lymphoma, the development of specialist expertise in the treatment of elderly patients with cancer is relatively recent. Treatment of the elderly is complex because they are a highly heterogeneous population, with large variations in health status, comorbidities and life expectancy. In addition, these patients are generally more susceptible than young patients to the cardiotoxic effects of anthracyclines. Strategies for assessing elderly patients with cancer, reducing the risk of congestive heart failure, and assessing the cardiotoxic effects of treatments are discussed. In addition, a summary of the SIOG recommendations is presented.http://www.pagepress.org/journals/index.php/hr/article/view/3873SIOG recommendations, non-Hodgkin’s lymphoma, elderly patients, anthracycline, treatment, cardiotoxicity
spellingShingle Matti Aapro
SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly
Hematology Reports
SIOG recommendations, non-Hodgkin’s lymphoma, elderly patients, anthracycline, treatment, cardiotoxicity
title SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly
title_full SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly
title_fullStr SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly
title_full_unstemmed SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly
title_short SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly
title_sort siog international society of geriatric oncology recommendations for anthracycline use in the elderly
topic SIOG recommendations, non-Hodgkin’s lymphoma, elderly patients, anthracycline, treatment, cardiotoxicity
url http://www.pagepress.org/journals/index.php/hr/article/view/3873
work_keys_str_mv AT mattiaapro sioginternationalsocietyofgeriatriconcologyrecommendationsforanthracyclineuseintheelderly